Skip to content

Retinai Medical AG

SwitzerlandFDA applicant, unverified

Devices
1

What Retinai Medical AG makes

Retinai Medical AG makes RetinAI Discovery, a software device used for ophthalmic imaging analysis.

RetinAI Discovery is a Class II medical device listed in the FDA 510(k) registry, and the company is based in the United States.

AI-generated from registry data, 3 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

  • RetinAI Discovery Ref K211715

    Active Regimes: 510(k) Registry: 510(k) Class:II

Frequently asked questions

How many devices does Retinai Medical AG have in the registry?

The registry currently lists 1 device for Retinai Medical AG. Devices recorded under merged duplicate company entries are counted once.

Which registries list Retinai Medical AG's devices?

Among its 1 most recently registered device, Retinai Medical AG has devices listed in FDA 510(k) (1 device).

What risk classes do Retinai Medical AG's devices fall under?

Among its 1 most recently registered device, the classes recorded for Retinai Medical AG's devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Retinai Medical AG in the registry?

The most recently registered devices listed for Retinai Medical AG include RetinAI Discovery.

Generated automatically from registry data and not verified by a human reviewer.